Published in PLoS Negl Trop Dis on November 20, 2014
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome. Front Microbiol (2016) 0.79
MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors. PLoS Negl Trop Dis (2016) 0.77
Is Cryptococcus gattii a Primary Pathogen? J Fungi (Basel) (2015) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS (2009) 16.37
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis (2010) 11.65
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol (1984) 5.74
Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis (2000) 3.71
Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis (2003) 3.34
Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis (1995) 3.13
Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis (2011) 2.97
Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol (2009) 2.80
Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog (2010) 2.67
Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol (2005) 2.63
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis (1998) 2.44
Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol (2004) 2.38
Cryptococcosis in apparently immunocompetent patients. QJM (2006) 2.09
Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis (1996) 2.02
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis (2010) 1.94
Cryptococcus neoformans var. gattii in Australia. J Clin Microbiol (1987) 1.92
Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis (1994) 1.80
Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis (2005) 1.79
Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis (2010) 1.78
Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis (2008) 1.72
Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg (1997) 1.63
Clonal reproduction and limited dispersal in an environmental population of Cryptococcus neoformans var gattii isolates from Australia. J Clin Microbiol (2003) 1.58
Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One (2009) 1.56
Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res (2006) 1.54
Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J Clin Microbiol (2005) 1.53
Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. MBio (2014) 1.45
Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res (2006) 1.43
A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis (2010) 1.39
A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog (2011) 1.38
Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis (2005) 1.34
Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin Infect Dis (2006) 1.33
Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res (2010) 1.32
Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis (2010) 1.30
Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res (2006) 1.27
Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol (2005) 1.23
AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. J Infect (1999) 1.22
Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz (2008) 1.21
Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot Cell (2005) 1.18
Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting. Med Mycol (2009) 1.18
Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect Immun (2009) 1.18
Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol (2011) 1.17
Immunohistochemical diagnosis of Cryptococcus neoformans var. gattii infection in chronic meningoencephalitis: the first case in Japan. Intern Med (2001) 1.17
First isolation of Cryptococcus neoformans var. gattii, serotype C, from the environment in Colombia. Med Mycol (1998) 1.16
Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS One (2013) 1.15
Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis (2012) 1.13
Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect (2011) 1.11
Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol (1997) 1.10
Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates. PLoS One (2013) 1.10
Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand. PLoS Negl Trop Dis (2013) 1.09
Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis (2012) 1.09
Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population--an emerging outbreak in Australia. PLoS One (2011) 1.08
First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol (2005) 1.08
Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis (2012) 1.06
Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. FEMS Yeast Res (2003) 1.04
Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis (2011) 1.04
Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya. Mycoses (2007) 1.04
Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04
[Cryptococosis: clinical epidemiological laboratorial study and fungi varieties in 96 patients]. Rev Soc Bras Med Trop (2006) 1.03
Epidemiology of cryptococcosis in Malaysia. Mycoses (2010) 1.02
A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005-2007. AIDS (2012) 1.02
Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil. Mem Inst Oswaldo Cruz (2008) 1.01
Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Clin Microbiol Infect (2009) 1.01
[Cryptococcosis in children in the State of Pará, Brazil]. Rev Soc Bras Med Trop (2000) 0.99
Cryptococcus neoformans var. gattii in India. J Med Vet Mycol (1993) 0.99
Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII. Mycopathologia (2011) 0.99
In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana. Med Mycol (2010) 0.98
First report of Cryptococcus neoformans var. gattii serotype B from Greece. Med Mycol (2001) 0.97
Cryptococcus gattii: where do we go from here? Med Mycol (2011) 0.96
Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates. Mycoses (2004) 0.95
Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathologia (2011) 0.95
Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One (2011) 0.94
Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach. Med Mycol (2010) 0.94
Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Rev Inst Med Trop Sao Paulo (2008) 0.94
Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India. Med Mycol (2004) 0.90
Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Res (2007) 0.90
Cryptococcus neoformans in Papua New Guinea: a common pathogen but an elusive source. J Med Vet Mycol (1998) 0.89
Frequency of Cryptococcus species and varieties in México and their comparison with some Latin American countries. Rev Latinoam Microbiol (2000) 0.89
Cryptococcus gattii is killed by dendritic cells, but evades adaptive immunity by failing to induce dendritic cell maturation. J Immunol (2013) 0.89
Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol (2010) 0.89
First environmental isolation of Cryptococcus gattii serotype B, from Cúcuta, Colombia. Biomedica (2011) 0.89
Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea. Trans R Soc Trop Med Hyg (1996) 0.88
[Results of nine years of the clinical and epidemiological survey on cryptococcosis in Colombia, 1997-2005]. Biomedica (2007) 0.87
Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia (1996) 0.87
Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008. Med Mycol (2011) 0.86
Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil). Mem Inst Oswaldo Cruz (2011) 0.86
Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela. Mycopathologia (2008) 0.85
Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil. Rev Inst Med Trop Sao Paulo (2005) 0.85
An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. I. Description of the disease and of the strain. Ann Soc Belges Med Trop Parasitol Mycol (1970) 0.85
First reported isolation of Cryptococcus neoformans var. gattii from a patient in Singapore. J Clin Microbiol (2002) 0.84
Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil. Mycoses (2009) 0.84
Cryptococcus gattii infection in an immunocompetent patient from Southern Italy. Mycopathologia (2011) 0.83
[The epidemiological characteristics of 105 cases of cryptococcosis diagnosed in the Republic of Argentina between 1981-1990]. Rev Inst Med Trop Sao Paulo (1994) 0.83
Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010. Biomedica (2012) 0.82
Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts. Infect Immun (2014) 0.81
Clinical and microbiological features of cryptococcal meningitis. Rev Soc Bras Med Trop (2013) 0.81
[First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso]. Rev Soc Bras Med Trop (2010) 0.81
Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal. MBio (2014) 1.45
Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii. PLoS One (2014) 0.87
MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors. PLoS Negl Trop Dis (2016) 0.77
Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates. Sci Rep (2015) 0.76